iSpecimen Inc
NASDAQ:ISPC

Watchlist Manager
iSpecimen Inc Logo
iSpecimen Inc
NASDAQ:ISPC
Watchlist
Price: 0.3108 USD 0.26% Market Closed
Market Cap: 3m USD

iSpecimen Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

iSpecimen Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
iSpecimen Inc
NASDAQ:ISPC
Operating Income
-$12.7m
CAGR 3-Years
-29%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Operating Income
$889.5m
CAGR 3-Years
24%
CAGR 5-Years
21%
CAGR 10-Years
27%
Inspire Medical Systems Inc
NYSE:INSP
Operating Income
$36.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Operating Income
$230.1m
CAGR 3-Years
27%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Operating Income
$17.1m
CAGR 3-Years
-31%
CAGR 5-Years
-15%
CAGR 10-Years
-10%
W
Waystar Holding Corp
NASDAQ:WAY
Operating Income
$123.7m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

iSpecimen Inc
Glance View

Market Cap
3m USD
Industry
Health Care

iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. The company is headquartered in Lexington, Massachusetts and currently employs 59 full-time employees. The company went IPO on 2021-06-17. The firm designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The firm serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.

ISPC Intrinsic Value
0.2336 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

What is iSpecimen Inc's Operating Income?
Operating Income
-12.7m USD

Based on the financial report for Dec 31, 2024, iSpecimen Inc's Operating Income amounts to -12.7m USD.

What is iSpecimen Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-27%

Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for iSpecimen Inc have been -29% over the past three years , -27% over the past five years .

Back to Top